Taking into account that healthy human aging is associated with increased FGF21 level, further elevation of its concentration above physiological level in subjects with obesity, diabetes, chronic kidney disease, and cardiovascular disease may be considered as a compensation/counteraction mechanism of pathological metabolic changes or, it may be just a reflection of multi-organ failure. The gene discussed is FGF21; the disease is chronic kidney disease.